Telik Inc (NASDAQ:TELK)

CAPS Rating: 2 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Recs

0
Player Avatar bioman100 (< 20) Submitted: 8/24/2006 10:07:41 PM : Outperform Start Price: $501.60 TELK Score: -107.64

breakthrough cancer drugs in development

Report this Post Reply

Featured Broker Partners


Advertisement